About Kumar Brothers Pharma Private Limited
Data last updated:
Kumar Brothers Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC151712. Its GSTIN is 27AACCK5488R1ZL (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Surendra Bhabutmal Jain (Managing Director) and Kumarpal Bhabutmal Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹34.94 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹10.81 Lakh (net margin 0.3%) and EBITDA of ₹75.56 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 12% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.21 Cr and satisfied charges of ₹3 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kbppl.net.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressA1 Unit No 204 2nd Floor Centre Point Condominium 243A N.M.Joshimarg Bawlamasjid Delisle L, Ower Parel, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kumar Brothers Pharma Private Limited
The main business activity of Kumar Brothers Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kumar Brothers Pharma Private Limited FY 2025 filings available
Kumar Brothers Pharma Private Limited reported revenue of ₹34.94 Cr (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Kumar Brothers Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 6% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kumar Brothers Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹75.56 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.81 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kumar Brothers Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kumar Brothers Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumarpal Bhabutmal Jain Also directs: Kolor Bio - Genetics Private Limited | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
| Kunal Kumarpal Jain Also directs: Kolor Bio - Genetics Private Limited | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
| Surendra Bhabutmal Jain | Managing Director | 02 Mar 2005 | 21 Years 7 Months | Current |
| Bhavesh Surendra Jain | Director | 02 Mar 2005 | 21 Years 7 Months | Current |
Peer Comparison of Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Green Apple Health Care Private Limited | ₹35.17 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Pune, Maharashtra, India |
| Abhay Trading Private Limited | ₹35.1 Cr (FY 2022) | •••• | •••• | -43.0% | •••• | Mumbai, Maharashtra, India |
| Emjay Capfin Private Limited | ₹35.07 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Guwahati, Assam, India |
| Elixir Life Care Private Limited | ₹35.03 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Chennai, Tamil Nadu, India |
| Wiscon Pharmaceuticals Private Limited | ₹34.98 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Kumar Brothers Pharma Private Limited this company | ₹34.94 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Akshaya Scientifics Private Limited | ₹34.78 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Secunderabad, Telangana, India |
| Raghavam Logistics Private Limited | ₹34.67 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Raipur, Chhattisgarh, India |
| Medsol India Overseas Private Limited | ₹34.67 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Noida, Uttar Pradesh, India |
| Aril Bioscience Private Limited | ₹34.52 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Mumbai, Maharashtra, India |
| Drug Centre Delhi Private Limited | ₹34.44 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Kumar Brothers Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma Private Limited is audited by SURESH TARACHAND RATHOD for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SURESH TARACHAND RATHOD | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kumar Brothers Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kumar Brothers Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Apr 2015 | Hdfc Bank Limited | ₹1.5 Cr | Open |
| 05 Sep 2006 | Hdfc Bank Limited | ₹1.25 Cr | Open |
| 25 Oct 2005 | The United Western Bank Ltd. | ₹36 Lakh | Open |
| 26 Mar 1976 | Central Bank of India | ₹10 Lakh | Open |
| 21 Aug 2007 | Union Bank of India | ₹3 Cr | Satisfied |
Total charge records: 5 View all charges
Legal Cases of Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma Private Limited has 1 court case on record: 1 filed by Kumar Brothers Pharma. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed by the company against Vascular Therapeutics (India ) Private Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma Private Limited has a workforce of 25 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma Private Limited has 10 board changes on record since 2005: 7 appointments and 3 cessations. The latest: Kirtesh Surendra Jain ceased to be Director on 11 Feb 2022.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kumar Brothers Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kumar Brothers Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kumar Brothers Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCK5488R1ZL | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kumar Brothers Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumar Brothers Pharma Private Limited
Kumar Brothers Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 March 2005 (21+ years old) and is registered under CIN U24230MH2005PTC151712.
Kumar Brothers Pharma reported revenue of ₹34.94 Cr for FY 2024 (up 6% YoY).
Kumar Brothers Pharma has 4 current directors:
- Surendra Bhabutmal Jain - Managing Director
- Kumarpal Bhabutmal Jain - Director
- Kunal Kumarpal Jain - Director
- Bhavesh Surendra Jain - Director
Kumar Brothers Pharma reported a net profit of ₹10.81 Lakh (net margin 0.3%) and EBITDA of ₹75.56 Lakh (EBITDA margin 2.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kumar Brothers Pharma is 10% over three years and 12% over five years. In the latest year (FY 2024) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kumar Brothers Pharma is 27AACCK5488R1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kumar Brothers Pharma is U24230MH2005PTC151712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kumar Brothers Pharma has 1 court case on record: 1 filed by the company.
Kumar Brothers Pharma was incorporated on 02 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kumar Brothers Pharma by revenue are Green Apple Health Care Private Limited, Abhay Trading Private Limited, Emjay Capfin Private Limited, Elixir Life Care Private Limited, Wiscon Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Kirtesh Surendra Jain ceased to be Director on 11 Feb 2022. Kumarpal Bhabutmal Jain was appointed as Director on 03 Dec 2018. Kunal Kumarpal Jain was appointed as Director on 03 Dec 2018. Kumar Brothers Pharma has 10 board changes on record in total.